Long-Term Improvements Observed in Tralokinumab-Treated Patients with Moderate-to-Severe Atopic Dermatitis: an ECZTEND Interim Analysis. (2021). SKIN The Journal of Cutaneous Medicine, 5(6), s59. https://doi.org/10.25251/skin.5.supp.59